Qin, Jianli <br/><br/>
PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.  [electronic resource] 

 -  Oncology reports  06 2020 
 - 1885-1896 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2020.7571  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Animals<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Catechin--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Ovarian Neoplasms--drug therapy<br/>PTEN Phosphohydrolase--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>Xenograft Model Antitumor Assays